X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (33) 33
humans (33) 33
female (30) 30
index medicus (30) 30
oncology (25) 25
middle aged (16) 16
cancer (14) 14
adult (13) 13
article (13) 13
chemotherapy (13) 13
aged (12) 12
breast neoplasms - genetics (12) 12
prognosis (11) 11
breast neoplasms - pathology (10) 10
genetic predisposition to disease (9) 9
neoplasm staging (9) 9
survival (9) 9
mutation (8) 8
risk factors (8) 8
therapy (8) 8
tumors (8) 8
analysis (7) 7
breast neoplasms - drug therapy (7) 7
breast neoplasms - metabolism (7) 7
diagnosis (7) 7
genetic aspects (7) 7
medicine & public health (7) 7
pathology (7) 7
receptors, estrogen - metabolism (7) 7
risk (7) 7
antineoplastic agents - therapeutic use (6) 6
breast neoplasms - mortality (6) 6
case-control studies (6) 6
gene expression (6) 6
health aspects (6) 6
mortality (6) 6
patients (6) 6
treatment outcome (6) 6
african americans (5) 5
aged, 80 and over (5) 5
breast neoplasms - ethnology (5) 5
carcinoma (5) 5
care and treatment (5) 5
erbb-2 protein (5) 5
estrogen (5) 5
genetics (5) 5
genome-wide association (5) 5
medical and health sciences (5) 5
medicin och hälsovetenskap (5) 5
research (5) 5
women (5) 5
adjuvant chemotherapy (4) 4
age (4) 4
biomarkers, tumor (4) 4
breast (4) 4
breast neoplasms - etiology (4) 4
carcinoma, ductal, breast - mortality (4) 4
carcinoma, lobular - mortality (4) 4
european continental ancestry group (4) 4
expression (4) 4
gene expression profiling (4) 4
genes (4) 4
genetics & heredity (4) 4
genome-wide association study (4) 4
genotype (4) 4
hematology, oncology and palliative medicine (4) 4
medical prognosis (4) 4
medical research (4) 4
oligonucleotide array sequence analysis (4) 4
ovarian cancer (4) 4
receptors, estrogen - genetics (4) 4
survival rate (4) 4
trends (4) 4
united states - epidemiology (4) 4
womens health (4) 4
young women (4) 4
abridged index medicus (3) 3
african americans - genetics (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biomarkers, tumor - genetics (3) 3
breast neoplasms - epidemiology (3) 3
cancer therapies (3) 3
carcinomas (3) 3
clinical trials (3) 3
combination (3) 3
common variant (3) 3
complex (3) 3
confidence intervals (3) 3
cytotoxicity (3) 3
càncer d'ovari (3) 3
càncer de mama (3) 3
disease-free survival (3) 3
dna methylation (3) 3
european continental ancestry group - genetics (3) 3
experimental design (3) 3
genetic loci - genetics (3) 3
genomes (3) 3
immunohistochemistry (3) 3
medical colleges (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Breast Cancer Reports, ISSN 1943-4588, 12/2018, Volume 10, Issue 4, pp. 289 - 295
Clinical management of triple negative breast cancer (TNBC) is challenging as patients have heterogeneous responses to systemic therapy, and there is no... 
Heterogeneity | Molecular subtypes | Medicine & Public Health | Therapeutic implications | Clinical trials | Oncology | Internal Medicine | Surgical Oncology | Triple negative breast cancer | Medical colleges | Medical research | Chemotherapy | Algorithms | Analysis | Genes | Stem cells | Medicine, Experimental | Breast cancer | Gene expression | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2012, Volume 7, Issue 8
The correct affiliation list is: 1 Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, United States of America, 2 Department of... 
Antigens | Breast cancer | Immunogenicity | Experiments | Cancer
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2019, Volume 178, Issue 1, pp. 151 - 159
Approximately, 10% of breast cancers are hereditary. Identifying women at high risk for hereditary breast and ovarian cancer allows for early detection,... 
NCCN guidelines | Medicine & Public Health | Oncology | Genetics | Breast cancer | Deleterious mutation | African American | Care and treatment | Gene mutations | Analysis | Oncology, Experimental | Medical records | Medical tests | Research | Genetic screening | Ovarian cancer | African American women | Cancer
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e38783
Purpose: NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to... 
TUMOR-INFILTRATING LYMPHOCYTES | IMMUNE-RESPONSE | T-CELL RESPONSES | MELANOMA | GENE | MULTIDISCIPLINARY SCIENCES | OVARIAN | ANTIBODY | RECURRENCE | CD8+T-CELL | EXPRESSION | Receptors, Estrogen - metabolism | Prognosis | Breast Neoplasms - immunology | Humans | Middle Aged | Carcinoma, Ductal, Breast - immunology | Receptor, ErbB-2 - metabolism | Neoplasm Recurrence, Local - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Immunoenzyme Techniques | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | CD8-Positive T-Lymphocytes | Neoplasm Recurrence, Local - immunology | DNA Methylation | Neoplasm Grading | Antigens, Neoplasm - metabolism | Female | Membrane Proteins - metabolism | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Lobular - immunology | Enzyme-Linked Immunosorbent Assay | Neoplasm Recurrence, Local - metabolism | Antigens, Neoplasm - immunology | Antibodies, Neoplasm - blood | Membrane Proteins - immunology | Survival Rate | Breast Neoplasms - mortality | Carcinoma, Lobular - metabolism | Neoplasm Staging | Immunohistochemistry | Viral antibodies | Antigens | Medical research | Immunotherapy | Medicine, Experimental | Antibodies | Breast cancer | Disease susceptibility | T cells | Peptides | CD8 antigen | Cytotoxicity | Oncology | Lymphocytes T | Cancer therapies | Immunology | Lymphocytes | Immune system | Immune response | Melanoma | T cell receptors | Patients | ErbB-2 protein | Immune response (humoral) | Pathology | Immunogenicity | Experimental design | Medical prognosis | Breast | Tumors | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 05/2015, Volume 75, Issue 9 Supplement, pp. P4 - P4-14-04
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 812 - 824
The C-X-C chemokine receptor type 4 (CXCR4)–stromal cell-derived factor-1α (SDF-1α) axis regulates function and trafficking of immune cells and the tumour... 
CAPECITABINE | MESYLATE | ANTAGONIST | ONCOLOGY | ANTHRACYCLINE | LY2510924 | GROWTH | CXCR4 | TAXANE | TUMOR MICROENVIRONMENT | CHEMOTHERAPY | Analysis | Breast cancer | Metastasis
Journal Article
Breast Cancer: Targets and Therapy, ISSN 1179-1314, 12/2015, Volume 8, pp. 1 - 12
Breast cancer in young women is relatively rare compared to breast cancer occurring in older women. Younger women diagnosed with breast cancer also tend to... 
Breast cancer | Treatment | Diagnosis | Young women | Genetic disorders | Genes | Endocrine therapy | Systematic review | Mammography | Medical screening | Patients | Cancer therapies | Studies | Pregnancy | Ultrasonic imaging | Chemotherapy | Acids | Womens health | Biopsy | Medical prognosis | Bone density | Mutation | Health risk assessment | Age
Journal Article
Cancer, ISSN 0008-543X, 09/2011, Volume 117, Issue 18, pp. 4132 - 4140
Journal Article
Cancer, ISSN 0008-543X, 5/2015, Volume 121, Issue 9, pp. 1469 - 1476
Journal Article
Cancer, ISSN 0008-543X, 05/2015, Volume 121, Issue 9, pp. 1469 - 1476
Journal Article